RT Journal Article
SR Electronic
T1 Synthesis and Evaluation of a Hematoporphyrin Derivative in a Folate Receptor-targeted Solid-Lipid Nanoparticle Formulation
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 161
OP 166
VO 24
IS 1
A1 PHILLIP J. STEVENS
A1 MASARU SEKIDO
A1 ROBERT J. LEE
YR 2004
UL http://ar.iiarjournals.org/content/24/1/161.abstract
AB Purpose: This study was aimed at the synthesis, formulation and in vitro evaluation of folate receptor (FR)- targeted solid-lipid nanoparticles (SLNs) as a carrier for a lipophilic derivative of the photosensitizer hematoporphyrin (Hp), in FR-overexpressing tumor cells. Materials and Methods: FR-targeted hematoporphyrin-stearylamine (HpSa) SLN composed of Triolein:Egg-phosphatidylcholine (EPC):Tween-80 (T-80) (64:25:10), with 0.5 mole % of folatepolyethyleneglycol- cholesterol (FPC) or polyethyleneglycoldistearoylphosphatidylethanolamine (PEG-DSPE), were prepared by ethanol injection method. Stability of the SLN was monitored by changes in particle size at 4°C and drug retention at various time points. Cellular uptake and IC50 values of the FR-targeted formulations were determined in vitro in the FR (+) KB cells. Results: Stable targeted SLNs were prepared by ethanol injection encapsulating greater than 95 percent of 5 mole % of HpSa, having a mean diameter < 200 nm. In vitro cytotoxicity assay on the FR-targeted SLN gave IC50 of 1.57 μM in KB cells and non-targeted SLNs gave an IC50 of 5.17 μM. FR selectivity was confirmed by fluorescence microscopy. Conclusion: FR-targeted SLNs incorporating the lipophilic drug HpSa were capable of specific receptor binding in cultured KB cells, which warrants further investigation.